Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Melissa Arellano is active.

Publication


Featured researches published by Melissa Arellano.


Bioorganic & Medicinal Chemistry | 2008

Pharmacological and pharmacokinetic characterization of 2-piperazine-α-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists

Chen Chen; Fabio C. Tucci; Wanlong Jiang; Joe A. Tran; Beth A. Fleck; Sam R.J. Hoare; Jenny Wen; Takung Chen; Michael Johns; Stacy Markison; Alan C. Foster; Dragan Marinkovic; Caroline W. Chen; Melissa Arellano; John Harman; John Saunders; Haig Bozigian; Daniel L. Marks

A series of 2-piperazine-alpha-isopropylbenzylamine derivatives were synthesized and characterized as melanocortin-4 receptor (MC4R) antagonists. Attaching an amino acid to benzylamines 7 significantly increased their binding affinity, and the resulting compounds 8-12 bound selectively to MC4R over other melanocortin receptor subtypes and behaved as functional antagonists. These compounds were also studied for their permeability using Caco-2 cell monolayers and metabolic stability in human liver microsomes. Most compounds exhibited low permeability and high efflux ratio possibly due to their high molecular weights. They also showed moderate metabolic stability which might be associated with their moderate to high lipophilicity. Pharmacokinetic properties of these MC4R antagonists, including brain penetration, were studied in mice after oral and intravenous administrations. Two compounds identified to possess high binding affinity and selectivity, 10d and 11d, were studied in a murine cachexia model. After intraperitoneal (ip) administration of 1mg/kg dose, mice treated with 10d had significantly more food intake and weight gain than the control animals, demonstrating efficacy by blocking the MC4 receptor. Similar in vivo effects were also observed when 11d was dosed orally at 20mg/kg. These results provide further evidence that a potent and selective MC4R antagonist has potential in the treatment of cancer cachexia.


Bioorganic & Medicinal Chemistry Letters | 2008

Design and synthesis of 3-arylpyrrolidine-2-carboxamide derivatives as melanocortin-4 receptor ligands.

Joe A. Tran; Fabio C. Tucci; Melissa Arellano; Wanlong Jiang; Caroline W. Chen; Dragan Marinkovic; Beth A. Fleck; Jenny Wen; Alan C. Foster; Chen Chen

Based on 3-phenylpropionamides, a series of 3-arylpyrrolidine-2-carboxamide derivatives was designed and synthesized to study the effect of cyclizations as melanocortin-4 receptor ligands. It was found that the 2R,3R-pyrrolidine isomer possessed the most potent affinity among the four stereoisomers.


Bioorganic & Medicinal Chemistry Letters | 2012

Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: Identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomnia

Satheesh B. Ravula; Jinghua Yu; Joe A. Tran; Melissa Arellano; Fabio C. Tucci; Wilna J. Moree; Bin-Feng Li; Robert E. Petroski; Jianyun Wen; Siobhan Malany; Samuel R.J. Hoare; Ajay Madan; Paul D. Crowe; Graham Beaton

The structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles, 2-morpholine and 2-thiomorpholin-2-yl-1H-benzimidazoles are described. In the lead optimization process, the pK(a) and/or logP of benzimidazole analogs were reduced either by attachment of polar substituents to the piperidine nitrogen or incorporation of heteroatoms into the piperidine heterocycle. Compounds 9a and 9b in the morpholine series and 10g in the thiomorpholine series demonstrated improved selectivity and CNS profiles compared to lead compound 2 and these are potential candidates for evaluation as sedative hypnotics.


Medicinal Chemistry | 2008

Studies on the Structure-Activity Relationship of the Basic Amine of Phenylpiperazines as Melanocortin-4 Receptor Antagonists

Chen Chen; Joe A. Tran; Melissa Arellano; Beth A. Fleck; Joseph Pontillo; Dragan Marinkovic; Fabio C. Tucci; Jenny Wen; John Saunders

A series of piperazinephenethylamines were synthesized to study the contribution of a basic amine to binding affinity at the melanocortin-4 receptor. Several potent compounds from this series possessed subnanomolar K(i) values in a competition binding assay.


Archive | 2003

Substituted piperazine as melanocortin receptors ligands

Joseph Pontillo; Dragan Marinkovic; Marion Lanier; Joe Ahn Tran; Melissa Arellano; Jessica Parker; Jodie Nelson; Chen Chen; Caroline W. Chen; Wanglong Jiang; Nicole S. White; Fabio C. Tucci


Bioorganic & Medicinal Chemistry Letters | 2004

Piperazinebenzylamines as potent and selective antagonists of the human melanocortin-4 receptor.

Joseph Pontillo; Joseph A. Tran; Beth A. Fleck; Dragan Marinkovic; Melissa Arellano; Fabio C. Tucci; Marion Lanier; Jodie Nelson; Jessica Parker; John Saunders; Brian J. Murphy; Alan C. Foster; Chen Chen


Bioorganic & Medicinal Chemistry Letters | 2004

Structure–activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptor

Joseph Pontillo; Joseph A. Tran; Melissa Arellano; Beth A. Fleck; Rajesh Huntley; Dragan Marinkovic; Marion Lanier; Jodie Nelson; Jessica Parker; John Saunders; Fabio C. Tucci; Wanlong Jiang; Caroline W. Chen; Nicole S. White; Alan C. Foster; Chen Chen


Bioorganic & Medicinal Chemistry Letters | 2006

Arylpropionylpiperazines as antagonists of the human melanocortin-4 receptor

Wanlong Jiang; Fabio C. Tucci; Caroline W. Chen; Melissa Arellano; Joe A. Tran; Nicole S. White; Dragan Marinkovic; Joseph Pontillo; Beth A. Fleck; Jenny Wen; John Saunders; Ajay Madan; Alan C. Foster; Chen Chen


Bioorganic & Medicinal Chemistry Letters | 2005

A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated mice

Joseph Pontillo; Joseph A. Tran; Stacy Markison; Margaret Joppa; Beth A. Fleck; Dragan Marinkovic; Melissa Arellano; Fabio C. Tucci; Marion Lanier; Jodie Nelson; John Saunders; Sam R.J. Hoare; Alan C. Foster; Chen Chen


Journal of Medicinal Chemistry | 2007

Discovery of 1-{2 -[(1S ) -(3 -dimethylamino-propionyl )amino -2 -methylpropyl ] -4 -methyl-phenyl} -4 -[ (2R ) -methyl -3 -(4 -chlorophenyl )-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexia

Chen Chen, Chen Chen, Chen Chen,; Wanlong Jiang; Fabio C. Tucci; Joe A. Tran; Beth A. Fleck; Sam R. J. Hoare; Margaret Joppa; Stacy Markison; Jenny Wen; Yang Sai; Michael Johns; Ajay Madan; Takung Chen; Caroline W. Chen; Dragan Marinkovic; Melissa Arellano; and John Saunders; Alan C. Foster

Collaboration


Dive into the Melissa Arellano's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Chen Chen

Neurocrine Biosciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joe A. Tran

Neurocrine Biosciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge